Advertisement

Topics

Experimental Drug With San Antonio Roots Changes Home After Merger

14:13 EDT 8 Aug 2017 | Xconomy

San Antonio — Galena Biopharma, a Bay Area biotech that has been developing a cancer vaccine created by a San Antonio researcher, is merging with another immunotherapy company: Sellas Life Sciences Group, which will also be the name of the combined business. Sellas Life Sciences is developing multiple experimental cancer immunotherapies, including a treatment for […]

Original Article: Experimental Drug With San Antonio Roots Changes Home After Merger

NEXT ARTICLE

More From BioPortfolio on "Experimental Drug With San Antonio Roots Changes Home After Merger"

Quick Search
Advertisement
 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...